Alzheimer's disease (AD) is a progressive neurodegenerative disease. While pathogenetic mechanisms are unresolved, neuroinflammation appears to play a contributory or possibly even a causative role. A recently published study has described an expansion of terminally differentiated effector T cells in the peripheral blood of Alzheimer's patients, reminiscent of findings in individuals with chronic infection or autoimmune disease. Moreover, oligoclonal T cell population were found in the brain of AD patients, including T cells specific for EBV antigens. Based on our current studies of ex vivo tetramer-sorted cells specific for a variety of viral antigens, we propose here that chromatin accessibility mapping of such antigen-specific T cells is an excellent tool to determine whether they have a distinct activation or differentiation history compared to non-AD amyloid-negative individuals. Specifically, we will compare chromatin accessible sites in T cells specific for EBV latent and lytic antigens with varicella zoster virus and influenza antigens as controls. Detection of a unique pattern of chromatin accessibility would strongly support the notion that these T cells are actively involved in the disease process. Moreover, identification of such sites would allow us to infer transcription factor networks that regulate the differentiation of these T cells. In a second step, we plan to compare AD patients to non-AD amyloid-positive individuals to determine whether the T cell response is already present in the early stages of the disease. Conversely, a negative result would strongly imply that the reported expansion of and brain infiltration with oligoclonal T cell populations specific to EBV in Alzheimer's patients is non-specific.
Neuroinflammation is a hallmark of Alzheimer's disease, the most frequent form of dementia. Antiviral immune responses have been suspected to contribute to pathogenesis. This study proposes to characterize the epigenome of selected virus-specific T cells in Alzheimer's patients to reconstruct the history of the antiviral response to provide evidence for their involvement in the disease process.
| Ye, Zhongde; Li, Guangjin; Kim, Chulwoo et al. (2018) Regulation of miR-181a expression in T cell aging. Nat Commun 9:3060 |
| Zhang, Hui; Watanabe, Ryu; Berry, Gerald J et al. (2018) Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis. Circulation 137:1934-1948 |
| Li, Yinyin; Goronzy, Jörg J; Weyand, Cornelia M (2018) DNA damage, metabolism and aging in pro-inflammatory T cells: Rheumatoid arthritis as a model system. Exp Gerontol 105:118-127 |
| Goronzy, Jörg J; Hu, Bin; Kim, Chulwoo et al. (2018) Epigenetics of T cell aging. J Leukoc Biol 104:691-699 |
| Watanabe, Ryu; Maeda, Toshihisa; Zhang, Hui et al. (2018) MMP (Matrix Metalloprotease)-9-Producing Monocytes Enable T Cells to Invade the Vessel Wall and Cause Vasculitis. Circ Res 123:700-715 |
| Weyand, Cornelia M; Shen, Yi; Goronzy, Jorg J (2018) Redox-sensitive signaling in inflammatory T cells and in autoimmune disease. Free Radic Biol Med 125:36-43 |
| Yanes, Rolando E; Gustafson, Claire E; Weyand, Cornelia M et al. (2017) Lymphocyte generation and population homeostasis throughout life. Semin Hematol 54:33-38 |
| Kim, C; Fang, F; Weyand, C M et al. (2017) The life cycle of a T cell after vaccination - where does immune ageing strike? Clin Exp Immunol 187:71-81 |
| Goronzy, Jörg J; Weyand, Cornelia M (2017) Successful and Maladaptive T Cell Aging. Immunity 46:364-378 |
| Zhang, Hui; Watanabe, Ryu; Berry, Gerald J et al. (2017) Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis. Proc Natl Acad Sci U S A 114:E970-E979 |
Showing the most recent 10 out of 37 publications
